✦ LIBER ✦

The challenge of biosimilars

✍ Scribed by Mellstedt, H.; Niederwieser, D.; Ludwig, H.

Book ID: 121870557
Publisher: Oxford University Press
Year: 2008
Tongue: English
Weight: 325 KB
Volume: 19
Category: Article
ISSN: 0923-7534
DOI: 10.1093/annonc/mdm345

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The challenge of indication extrapolatio

The challenge of indication extrapolation for infliximab biosimilars

✍ Feagan, Brian G.; Choquette, Denis; Ghosh, Subrata; Gladman, Dafna D.; Ho, Vince 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 283 KB

Biosimilars: The Need, The Challenge, Th

✍ Epstein, Michael S; Ehrenpreis, Eli D; Kulkarni, Prasad M 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 153 KB

Biosimilars to treat inflammatory arthri

✍ Kay, J.; Smolen, J. S. 📂 Article 📅 2013 🏛 BMJ Publishing Group 🌐 English ⚖ 240 KB

Pharmacovigilance and biosimilars: consi

Pharmacovigilance and biosimilars: considerations, needs and challenges

✍ Casadevall, Nicole; Edwards, I Ralph; Felix, Thomas; Graze, Peter R; Litten, Jas 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 250 KB

Biosimilar monoclonal antibodies: a scie

✍ Declerck, Paul J 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 195 KB

Development and Regulation of Biosimilar

Development and Regulation of Biosimilars: Current Status and Future Challenges

✍ Tsiftsoglou, Asterios S. (author);Ruiz, Sol (author);Schneider, Christian K. (au 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 252 KB